Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 USD | +1.01% | -9.34% | 0.00% |
Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 222M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -94M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.31M | Net cash position 2025 * | 37.99M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.98
x | P/E ratio 2025 * |
-2.69
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.53% |
1 day | +1.01% | ||
1 week | -9.34% | ||
Current month | +1.01% | ||
1 month | -26.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 10 | +1.01% | 105,539 |
24-04-30 | 9.9 | -13.61% | 109,733 |
24-04-29 | 11.46 | -1.55% | 90,598 |
24-04-26 | 11.64 | -3.56% | 95,807 |
24-04-25 | 12.07 | +9.43% | 154,924 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 220M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- BOLD Stock